C9122 – Mometasone furoate sinus implant, 10 micrograms (sinuva)
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9122
- Long description
- Mometasone furoate sinus implant, 10 micrograms (sinuva)
- Short description
- Mometasone furoate (sinuva)
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J7402
- Added
- July 1, 2020
- Last change
- April 1, 2021 – No change
- Termination date
- March 31, 2021
Frequently asked questions
What is HCPCS code C9122?
C9122 is a HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms (sinuva). It was discontinued on March 31, 2021.
Does Medicare cover C9122?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9094 – Inj, sutimlimab-jome, 10 mg
- C9095 – Inj, tebentafusp-tebn, 1 mcg
- C9096 – Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- C9097 – Inj, faricimab-svoa, 0.1 mg
- C9098 – Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- C9101 – Injection, oliceridine, 0.1 mg
- C9113 – Injection, pantoprazole sodium, per vial
- C9121 – Injection, argatroban, per 5 mg
- C9132 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- C9133 – Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
- C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
- C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.
- C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
- C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
- C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.